Treatment of relapse of breast cancer after adjuvant systemic therapy — Review and guidelines for future research
✍ Scribed by Rubens, R.D.; Bajetta, E.; Bonneterre, J.; Klijn, J.G.M.; Lonning, P.E.; Paridaens, R.
- Book ID
- 122015505
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 638 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Adjuvant treatment is administered prior to or as follow up to surgical procedures for breast cancer. Proven success in using medical therapies allowing for breast conserving procedures or reducing risk of occurrence. Although there has been much progress towards a cure, including the introduction o
Adjuvant systemic treatments have greatly improved the prognosis of women with early breast cancer. Combination chemotherapy and, for patients with oestrogen receptor-positive (ER+) tumours, endocrine treatment has been found to reduce the frequency of relapse and improve survival. New adjuvant stra